Related Experiment Video
Updated: Apr 24, 2026

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
Published on: May 18, 2020
Effect of glycogen synthase kinase-3 inactivation on mouse mammary gland development and oncogenesis
J Dembowy1, H A Adissu2, J C Liu3
11] Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada [2] Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
Abstract:
Many components of the Wnt/β-catenin signaling pathway have critical functions in mammary gland development and tumor formation, yet the contribution of glycogen synthase kinase-3 (GSK-3α and GSK-3β) to mammopoiesis and oncogenesis is unclear. Here, we report that WAP-Cre-mediated deletion of GSK-3 in the mammary epithelium results in activation of Wnt/β-catenin signaling and induces mammary intraepithelial neoplasia that progresses to squamous transdifferentiation and development of adenosquamous carcinomas at 6 months. To uncover possible β-catenin-independent activities of GSK-3, we generated mammary-specific knockouts of GSK-3 and β-catenin. Squamous transdifferentiation of the mammary epithelium was largely attenuated, however, mammary epithelial cells lost the ability to form mammospheres suggesting perturbation of stem cell properties unrelated to loss of β-catenin alone. At 10 months, adenocarcinomas that developed in glands lacking GSK-3 and β-catenin displayed elevated levels of γ-catenin/plakoglobin as well as activation of the Hedgehog and Notch pathways. Collectively, these results establish the two isoforms of GSK-3 as essential integrators of multiple developmental signals that act to maintain normal mammary gland function and suppress tumorigenesis.
Insights
Glycogen synthase kinase-3 (GSK-3) is crucial for mammary gland development and tumor suppression. Its deletion activates Wnt signaling, leading to mammary tumors and altered stem cell properties.
Area of Science:
- Cellular and Molecular Biology
- Developmental Biology
- Cancer Research
Background:
- Wnt/β-catenin signaling is vital for mammary gland development and tumorigenesis.
- The specific roles of glycogen synthase kinase-3 (GSK-3α and GSK-3β) in mammopoiesis and oncogenesis remain largely undefined.
Purpose of the Study:
- To investigate the contribution of GSK-3 to mammary gland development and tumorigenesis.
- To elucidate the β-catenin-dependent and -independent functions of GSK-3 in the mammary epithelium.
Main Methods:
- Mammary-specific knockout of GSK-3 using WAP-Cre.
- Generation of mammary-specific double knockouts of GSK-3 and β-catenin.
- Histological analysis and assessment of mammary stem cell properties (mammosphere formation).
Main Results:
- Deletion of GSK-3 in mammary epithelium activates Wnt/β-catenin signaling, inducing mammary intraepithelial neoplasia and adenosquamous carcinomas.
- Loss of GSK-3 and β-catenin attenuates squamous transdifferentiation but impairs mammary epithelial stem cell function.
- Tumors lacking GSK-3 and β-catenin exhibit elevated γ-catenin/plakoglobin and activated Hedgehog and Notch pathways.
Conclusions:
- GSK-3 isoforms are essential regulators of mammary gland development and suppress tumorigenesis.
- GSK-3 integrates multiple signaling pathways, including Wnt, Hedgehog, and Notch, to maintain mammary gland homeostasis.
- GSK-3 plays critical roles in both β-catenin-dependent and -independent pathways governing mammary epithelial stem cell function.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Abnormal Proliferation

